Overview strategies for blood donor selection vCJD
Several recent publications on transfusion risk assessment of variant Creutzfeldt-Jakob disease (vCJD) have led to changes in donor selection criteria[…]
Several recent publications on transfusion risk assessment of variant Creutzfeldt-Jakob disease (vCJD) have led to changes in donor selection criteria[…]
How to ensure sufficiency of substances of human origin (SoHO) while improving the protection and welfare of our donors? And[…]
Brussels, 22 May 2023 Dear Member of the ENVI Committee, We are writing to you on behalf of the Common[…]
On December 9th, the European Blood Alliance (EBA) presented the “Implementation of Whole Blood for Transfusion” webinar, supported by the[…]
Recent updates regarding variant Creutzfeldt-Jakob disease risk assessments and impact on blood and plasma collection in Europe The emergence of[…]
GENERAL POSITION ON THE PROPOSAL OF THE EUROPEAN COMMISSION FOR A REGULATION ON STANDARDS OF QUALITY AND SAFETY FOR SUBSTANCES[…]
CoRe SoHO statement welcoming the proposed Regulation on standards of quality and safety for substances of human origin (SoHO) intended[…]
Submitted on 26 July 2022 The European Blood Alliance (EBA) welcomes this proposal on the European Health Data Space (EHDS).[…]